Paper · 2026 · Open access

EMERGING STRATEGIES TO ENHANCE ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS: FROM BCS CLASSIFICATION TO ADVANCED DELIVERY SYSTEMS

Kumbhar Dnyaneshwari Vitthal*, Khandagale Pranoti Abaso, Lavand Yash Vishal, Vagare Dnyaneshwari Balasaheb

Zenodo (CERN European Organization for Nuclear Research) · Published 22 March 2026 · DOI 10.5281/zenodo.19162236

Read the free full textCite this paper

In brief

“EMERGING STRATEGIES TO ENHANCE ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS: FROM BCS CLASSIFICATION TO ADVANCED DELIVERY SYSTEMS” is a 2026 paper by Kumbhar Dnyaneshwari Vitthal*, Khandagale Pranoti Abaso, Lavand Yash Vishal, Vagare Dnyaneshwari Balasaheb, published in Zenodo (CERN European Organization for Nuclear Research). OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Zenodo (CERN European Organization for Nuclear Research).

Citations
0
Authors
1

Abstract

Pharmaceutical nanotechnology has emerged as a powerful approach in modern drug development, addressing critical limitations associated with conventional drug delivery systems such as poor solubility, low bioavailability, and systemic toxicity. Lipid-based and polymeric nanocarriers have gained significant importance due to their ability to enhance drug stability, improve targeted delivery, and provide controlled release. Lipid nanocarriers, including liposomes, solid lipid nanoparticles (SLNs), and nanostructured lipid carriers (NLCs), offer excellent biocompatibility and high drug encapsulation efficiency. Polymeric nanocarriers such as polymeric nanoparticles, micelles, and dendrimers enable sustained release and site-specific targeting. These systems significantly improve therapeutic outcomes while reducing adverse effects and enhancing patient compliance. This review discusses classification, mechanisms, advantages, applications, and future prospects of lipid and polymeric nanocarriers in pharmaceutical sciences. Keywords: Pharmaceutical nanotechnology, Lipid nanocarriers, Polymeric nanoparticles, Targeted drug delivery, Controlled release, Drug development

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Balasaheb, K. D. V. K. P. A. L. Y. V. V. D. (2026). EMERGING STRATEGIES TO ENHANCE ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS: FROM BCS CLASSIFICATION TO ADVANCED DELIVERY SYSTEMS. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.19162236

MLA 9

Balasaheb, Kumbhar Dnyaneshwari Vitthal*, Khandagale Pranoti Abaso, Lavand Yash Vishal, Vagare Dnyaneshwari. “EMERGING STRATEGIES TO ENHANCE ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS: FROM BCS CLASSIFICATION TO ADVANCED DELIVERY SYSTEMS.” Zenodo (CERN European Organization for Nuclear Research), 2026. https://doi.org/10.5281/zenodo.19162236.

Chicago

Balasaheb, Kumbhar Dnyaneshwari Vitthal*, Khandagale Pranoti Abaso, Lavand Yash Vishal, Vagare Dnyaneshwari. 2026. “EMERGING STRATEGIES TO ENHANCE ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS: FROM BCS CLASSIFICATION TO ADVANCED DELIVERY SYSTEMS.” Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.19162236.

Harvard

Balasaheb, K. D. V. K. P. A. L. Y. V. V. D. (2026) ‘EMERGING STRATEGIES TO ENHANCE ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS: FROM BCS CLASSIFICATION TO ADVANCED DELIVERY SYSTEMS’, Zenodo (CERN European Organization for Nuclear Research). doi:10.5281/zenodo.19162236.

IEEE

K. D. V. K. P. A. L. Y. V. V. D. Balasaheb, “EMERGING STRATEGIES TO ENHANCE ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS: FROM BCS CLASSIFICATION TO ADVANCED DELIVERY SYSTEMS,” Zenodo (CERN European Organization for Nuclear Research), 2026, doi: 10.5281/zenodo.19162236.

BibTeX

@article{balasaheb2026emerging,
  title     = {{EMERGING STRATEGIES TO ENHANCE ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS: FROM BCS CLASSIFICATION TO ADVANCED DELIVERY SYSTEMS}},
  author    = {Balasaheb, Kumbhar Dnyaneshwari Vitthal*, Khandagale Pranoti Abaso, Lavand Yash Vishal, Vagare Dnyaneshwari},
  journal   = {Zenodo (CERN European Organization for Nuclear Research)},
  year      = {2026},
  doi       = {10.5281/zenodo.19162236},
  url       = {https://doi.org/10.5281/zenodo.19162236}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems

  • oral bioavailability
  • poorly water-soluble drugs
  • BCS classification
  • pharmaceutical nanotechnology
  • lipid-based nanocarriers
  • polymeric nanocarriers
  • liposomes
  • solid lipid nanoparticles

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Balasaheb, K. D. V. K. P. A. L. Y. V. V. D. (2026). EMERGING STRATEGIES TO ENHANCE ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS: FROM BCS CLASSIFICATION TO ADVANCED DELIVERY SYSTEMS. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.19162236

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Zenodo (CERN European Organization for Nuclear Research).

Who wrote this paper?

Kumbhar Dnyaneshwari Vitthal*, Khandagale Pranoti Abaso, Lavand Yash Vishal, Vagare Dnyaneshwari Balasaheb.

What is the DOI of this paper?

10.5281/zenodo.19162236. The permanent link is https://doi.org/10.5281/zenodo.19162236.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.